Allen J Dozor MD Appointed President of Boston Children’s Health Physicians

Allen J Dozor MD  has a long and distinguished history with the organization, most recently serving as Interim Vice President since April 2020.

Dr. Dozor is a longtime member of the Boston Children’s family since he joined the faculty and attending staff at Boston Children’s Hospital in 1982. Dr. Dozor moved to Westchester and accepted the position of Chief of Pediatric Pulmonology at New York Medical College and Director of the Pediatric Intensive Care Unit at Westchester Medical Center in 1985 and has since devoted his professional career to the growth of the organization, to the care of patients, and to the advancement of multiple academic endeavors.

Allen J Dozor MD founded the Division of Pediatric Pulmonology, Allergy, Immunology, and Sleep Medicine at BCHP (formerly CWPW) and has also served as the Director of the Armond V. Mascia, MD Cystic Fibrosis Center, the only such center in the Hudson Valley. Additionally, he founded and directed the fellowship in Pediatric Pulmonology, he has served as the Associate Physician-in-Chief at Maria Fareri Children’s Hospital at Westchester Medical Center since its inception, and in 2008 he co-founded the Children’s Environmental Health Center of the Hudson Valley. Dr. Dozor also serves as Professor of Pediatrics and Clinical Public Health at New York Medical College.

“We are grateful for the many contributions which Dr. Dozor has made to the field of Pediatrics, and congratulate him on his appointment as the next President of BCHP. His tireless efforts and commitment have hugely impacted BHCP and our patients in a positive manner,” says Gerard Villucci, CEO. “We know that as President, he will help lead BCHP to new heights and enable our practice to provide our patients with the highest quality treatments and care. Dr. Dozor’s extensive leadership experience will allow BCHP to continue to respond to the ever changing demands of the pediatric community.”

Dr. Dozor states, “I am humbled to take on this new role. My goals as a physician align with my goals as president. I am so proud of the growth of BCHP, and its long-standing commitment to superb patient care, medical research, training future generations of physicians, and advocating for the current and future health and well-being of children and families.”

Under Dr. Dozor’s leadership, the future is bright as he continues to make strides for BCHP and their patients. BCHP enthusiastically welcomes Dr. Dozor as their new president.

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version